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n the last few decades, the occurrence
oftype2diabeteshasrapidlyincreased
internationally, and it has been esti-
mated that the number of diabetic pa-
tients will more than double within 15
years (1). Type 2 diabetes is mainly char-
acterizedbythedevelopmentofincreased
morbidity and mortality for cardiovascu-
lar disease (CVD); thus, it has been sug-
gested that diabetes may be considered a
CVD (1). However, diabetes is also char-
acterized by dramatic microangiophatic
complications, such as retinopathy, ne-
phropathy, and neuropathy (1).
Recentevidencesuggeststhatglucose
overload may damage the cells through
oxidative stress (2). This is currently the
basis of the “unifying hypothesis” that hy-
perglycemia-induced oxidative stress
may account for the pathogenesis of all
diabetic complications (2).
CENTRAL ROLE OF
OXIDATIVE STRESS IN THE
PATHOGENESIS OF
DIABETIC COMPLICATIONS—
It has been suggested that the following
four key biochemical changes induced by
hyperglycemia are all activated by a com-
mon mechanism—overproduction of su-
peroxide radicals (2): 1) increased ﬂux
through the polyol pathway (in which
glucose is reduced to sorbitol, reducing
levels of both NADPH and reduced gluta-
thione); 2) increased formation of ad-
vancedglycationendproducts(AGEs);3)
activationofproteinkinaseC(witheffects
ranging from vascular occlusion to ex-
pression of proinﬂammatory genes), and
4) increased shunting of excess glucose
through the hexosamine pathway (medi-
ating increased transcription of genes for
inﬂammatory cytokines). Excess plasma
glucose drives excess production of elec-
tron donors (mainly -NADH/H
) from
the tricarboxylic acid cycle; in turn, this
surfeitresultsinthetransferofsingleelec-
trons (instead of the usual electron pairs)
to oxygen, producing superoxide radicals
andotherreactiveoxygenspecies(instead
of the usual H2O end product). The su-
peroxide anion itself inhibits the key
glycolytic enzyme glyceraldehyde-3-
phosphatedehydrogenase(GADPH),and
consequently, glucose and glycolytic in-
termediates spill into the polyol and hex-
osamine pathways, as well as additional
pathwaysthatculminateinproteinkinase
C activation and intracellular AGE forma-
tion (Fig. 1).
However, superoxide overproduc-
tion is also accompanied by increased ni-
tric oxide generation, due to endothelial
nitric oxide synthase and inducible nitric
oxide synthase uncoupled state (3), a
phenomenon favoring the formation of
thestrongoxidantperoxynitrite,whichin
turndamagesDNA(3).TheDNAdamage
isanobligatorystimulusfortheactivation
of the nuclear enzyme poly(ADP-ribose)
polymerase (4). Poly(ADP-ribose) poly-
merase activation in turn depletes the in-
tracellular concentration of its substrate
NAD
, slowing the rate of glycolysis,
electron transport, and ATP formation,
and produces an ADP ribosylation of the
glyceraldehyde-3-phosphate dehydroge-
nase (4). These processes result in endo-
thelial dysfunction (Fig. 2).
These pathways are conﬁrmed by at
least one study on the perfusion for2ho f
isolated rat hearts with solutions of 11.1
mmol/l glucose, 33.3 mmol/l glucose, or
33.1 mmol/l glucose plus glutathione. In
the hearts perfused with high glucose
concentrations, coronary perfusion pres-
surewassigniﬁcantlyincreased;therewas
a 40% increase in nitric oxide (NO) levels
and an upregulation of inducible nitric
oxide synthase, but a 300% increase in
the production of superoxide species; ni-
trotyrosine and cardiac cell apoptosis
were also signiﬁcantly increased (5). All
these effects were substantially prevented
by glutathione, which effectively removes
reactive oxygen species including per-
oxynitrite (5).
However, more recently, evidence
from in vitro studies suggests that
markedﬂuctuationsinglucoselevels,as
seen in diabetic patients, have conse-
quences that are even more deleterious
than those of continuous high glucose
levels and that oxidative stress is con-
vincingly involved. For example, in
cultures of human umbilical vein endo-
thelial cells, levels of nitrotyrosine (a
markerofoxidativestress),intercellular
adhesion molecule-1, vascular cellular ad-
hesion molecule-1, E-selectin, interleu-
kin-6, and 8-hydroxydeoxyguanosine (a
markerofoxidativedamageofDNA)were
allincreasedafterincubationinamedium
containing 20 mmol/l glucose, compared
with a (interleukin [IL]-6) 5 mmol/l glu-
cosemedium,butalternatingthetwome-
dia caused even greater increases (6–8).
In addition, intermittent hyperglycemic
conditions increased rates of cellular ap-
optosis and stimulated the expression of
caspase-3 (a pro-apoptotic protein), but
decreased bcl-2 (an anti-apoptotic pro-
tein). These effects were abolished by
adding superoxide dismutase (which
scavenges free radicals) or inhibitors of
the mitochondrial electron transport
chain, suggesting that overproduction of
freeradicalsinthemitochondriamediates
the apoptotic effects of increased glucose
concentrations and ﬂuctuations (9).
OXIDATIVE STRESS IN
DIABETES: IN VIVO
EVIDENCE— The response-to-injury
hypothesis of atherosclerosis states that
the initial damage affects the arterial en-
dothelium, in terms of endothelial dys-
function. Notably, today’s evidence
conﬁrmsthatendothelialdysfunction,as-
sociated with oxidative stress, predicts
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high glucose concentrations induce en-
dothelial dysfunction in diabetic as well
as normal subjects (3). The role of free
radical generation in producing the hy-
perglycemia-dependent endothelial
dysfunction is suggested also by studies
showing that the acute effects of hyper-
glycemia are counterbalanced by anti-
oxidants (11,12).
Numerous studies have also noted
the effect of hyperglycemia-induced oxi-
dative stress on inﬂammation. A study in
which insulin secretion was blocked, and
subjects were maintained at plasma glu-
cose levels of 15 mmol/l for 5 h, found
that levels of IL-6, tumor necrosis fac-
tor-, and the proinﬂammatory cytokine
IL-18 rose signiﬁcantly and returned to
baseline within3hi nt h econtrol group
(13). However, patients with impaired
glucose tolerance had signiﬁcantly higher
tumor necrosis factor- and IL-6 at base-
line levels, and cytokine levels reached
substantially higher peaks and stayed el-
evated for considerably longer than in the
control subjects (13). All changes in
plasma cytokine levels were abolished by
infusion of the antioxidant glutathione,
consistentwiththehypothesisthathyper-
glycemia, especially in the form of spikes,
is linked to immune activation via an ox-
idative mechanism (13). Another study
matching diabetic patients and healthy
control subjects found increases in circu-
lating intercellular adhesion molecule-1
(ICAM-1) in both groups during an oral
glucose tolerance test; these increases
were also abolished by glutathione (14).
Glutathione administered without a glu-
cose load decreased circulating ICAM-1
levels in the diabetic group, but not in the
control group, again suggesting that hy-
perglycemia increases ICAM-1 levels via
an oxidative mechanism (14).
More direct evidence for the central
role of oxidative stress is derived from
clinical studies that measured the mark-
ers. For example, among 20 diabetic pa-
tients, either a low-carbohydrate or high-
carbohydrate meal increased levels of
plasmaglucose,insulin,triglycerides,and
malondialdehyde (a marker for lipid per-
oxidation) and decreased nonesteriﬁed
fatty acids and total radical-trapping anti-
oxidant parameter (TRAP) (a global mea-
sure of antioxidant capacity in the
plasma) (15). However, the high-
carbohydrate meal (designed to produce
higher postprandial glucose levels) in-
creased glucose and malondialdehyde,
decreased TRAP signiﬁcantly more, and
rendered LDL more susceptible to oxida-
tion than did the low-carbohydrate meal
(15). The decrease in TRAP highlights the
fact that oxidative stress may also ensue
fromthefailureofnormalantioxidantde-
fenses: the same group found that during
the oral glucose tolerance test, TRAP was
reduced from baseline in both well-
controlled nonsmoking diabetic and
healthy age-matched subjects, as were
levels of protein-bound thiol (sulphur)
groups, vitamins C and E, and uric acid
(15).
Asaforementioned,superoxideanion
combines with NO to produce peroxyni-
trite ion; this species is capable of peroxi-
dating lipoproteins and damaging DNA,
which then activates the nuclear enzyme
poly (APD-ribose) polymerase, depleting
intracellular NAD
 and (among other ef-
fects) causing acute endothelial dysfunc-
tion (3). In one study involving 12
healthysubjects,infusionof L-arginine(to
supply NO) reversed hyperglycemia-
inducedincreasesinsystolicanddiastolic
blood pressure, heart rate, plasma cate-
cholamine levels, ADP-induced platelet
aggregation, and blood viscosity (16).
However, infusing N
G-monomethyl-L-
arginine, which inhibits the synthesis of
endogenous NO, produced effects that
Figure 1—Potential mechanism by which hyperglycemia-induced mitochondrial superoxide overproduction activates four pathways of hypergly-
cemic damage. Excess superoxide partially inhibits the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH), thereby diverting
upstreammetabolitesfromglycolysisintopathwaysofglucoseoverutilization.Thisresultsinincreasedﬂuxofdihydroxyacetonephosphate(DHAP)
to diacylglycerol (DAG), an activator of protein kinase C (PKC), and of triose phosphates to methylglyoxal, the main intracellular AGE precursor.
Increased ﬂux of fructose-6-phosphate (Fructose-6-P) to UDP-N-acetylglucosamine increases modiﬁcation of proteins by O-linked N-
acetylglucosamine(GIcNAc),andincreasedglucoseﬂuxthroughthepolyolpathwayconsumesNADPHanddepletesglutathione.GFAT,glutamine:
fructose-6-phosphate aminotransferase; Gln, glutamine; Glu, glutamate; NAD
, nicotinamide dinucleotide; UDP, uridine diphosphate.
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glycemia. Thus, decreased NO availabil-
ity may be one mechanism by which
hyperglycemia induces hemodynamic
and rheological changes in blood (16). It
has been shown, however, that unlike
normal control subjects, patients with di-
abetes have signiﬁcantly elevated fasting
nitrotyrosine levels, as well as postpran-
dial increases, after intake of a standard
mixed meal; the effect was signiﬁcantly
normalized by insulin aspart (which tar-
gets postprandial glucose) but not by reg-
ular insulin (17).
Finally, consistent with the recent
emerging role of glucose ﬂuctuations, a
new study conﬁrms that, in type 2 diabe-
tes, diurnal glucose ﬂuctuations are the
most powerful predictors of oxidative
stress generation (18).
NEW PERSPECTIVES:
OXIDATIVE STRESS AND
HYPERGLYCEMIA-INDUCED
“METABOLIC MEMORY”— Large
randomized studies have established that
early intensive glycemic control reduces
the risk of diabetic complications, both
micro-andmacrovascular(19).However,
epidemiological and prospective data
support a long-term inﬂuence of early
metabolic control on clinical outcomes
(19).Thisphenomenonhasrecentlybeen
deﬁned as “metabolic memory” (19). Po-
tential mechanisms for propagating this
“memory” are the nonenzymatic glyca-
tionofcellularproteinsandlipids,andan
excess of cellular reactive oxygen and ni-
trogen species, in particular, those that
originated at the level of glycated-
mitochondrialproteins,perhapsactingin
concert with one another to maintain
stress signaling (19).
Experimental evidence supporting
the concept of “metabolic memory”
and its possible link with oxidative
stress
Several years ago, there were preliminary
reports of the possibility that “hypergly-
cemic memory” for hyperproduction of
ﬁbronectin and collagen in endothelial
cells persists after glucose normalization
(20). Using the same design, i.e., 14 days
in high glucose followed by 7 days of cul-
tureinnormalglucose,itwasshownthat,
in endothelial cells, an overproduction of
free radicals persists after the normaliza-
tion of glucose and is accompanied by a
prolongation of the induction of protein
kinase-, NAD(P)H oxidase, Bax, colla-
gen, and ﬁbronectin, in addition to 3-ni-
trotyrosine (21). This result suggests that
oxidative stress may be involved in the
“metabolic memory” effect.
Theeffectofreinstitutionofgoodglu-
cose control on hyperglycemia-induced
increased oxidative stress and nitrative
stresswasalsopreviouslyevaluatedinthe
retina of rats maintained in poor glucose
control before initiation of good control
(22). In diabetic rats, 2 or 6 months of
poor control (A1C 11.0%) was fol-
lowed by 7 months of good control (A1C
5.5%). Reinstitution of good control af-
ter 2 months of poor control inhibited el-
evationsinretinallipidperoxidesandNO
levels by 50%, but failed to have any
beneﬁcial effects on nitrotyrosine forma-
tion. However, reversal of hyperglycemia
after 6 months of poor control had no
signiﬁcant effect on retinal oxidative
stress and NO levels. In the same rats,
inducible nitric oxide synthase expres-
sion and nitrotyrosine levels remained el-
evated by 80% compared with normal
rats, or rats kept in good control for the
duration (22). In a similar study,
caspase-3 activity in diabetic rats kept in
poor control for 13 months was higher
than in normal rats (23). Reinstitution of
good glycemic control after 2 months of
poor control partially normalized the hy-
perglycemia-induced activation of
caspase-3 (to 140% of normal values),
whereas reinstitution of good control af-
ter 6 months of poor control had no sig-
niﬁcant effect on the activation of
caspase-3. In the same study, nuclear fac-
tor (NF)-B activity was 2.5-fold higher
in diabetic rats kept in poor control than
in normal rats. Reinstitution of good con-
trol after 2 months of poor control par-
Figure 2—In the cells, hyperglycemia induces overproduction of superoxide at the mitochondrial
level and nitric oxide overproduction through both inducible nitric oxide synthase (iNOS) and
endothelial nitric oxide synthase (eNOS). Whereas protein kinase C (PKC) and NF-B are also
activated and favor an overexpression of the enzyme NAD(P)H. NAD(P)H generates a great
amount of superoxide. Superoxide overproduction, accompanied by increased nitric oxide gener-
ation,favorstheformationofthestrongoxidantperoxynitrite,whichinturndamagesDNA.DNA
damage is an obligatory stimulus for the activation of the nuclear enzyme poly(ADP-ribose)
polymerase (PARP). PARP activation in turn reduces the glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) activity. This process results in endothelial dysfunction, which, in turn, con-
tributes to the development of diabetic complications. The new approach to a possible natural
antioxidant therapy now takes into account three different possibilities: Vitamins, substances that
canbalancefreeradicalproductionatthemitochondriallevel,andsubstancesabletoinducetheir
own antioxidant defenses in the cells. All these three different substance types are present in
vegetables. Adapted from Ceriello (3).
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controlafter6monthsofpoorcontrolhad
no effect. Initiation of good control soon
after induction of diabetes in rats pre-
vented activation of retinal caspase-3 and
NF-B (23). Similar results are available
for the kidney. Diabetic rats were main-
tainedingoodglycemiccontrol(A1C5%)
soon, or 6 months after, induction of hy-
perglycemia and were killed 13 months
after induction of diabetes (24). For rats
in which good control was initiated soon
after induction of diabetes, oxidative
stress (as measured by the levels of
lipid peroxides, 8-hydroxy-2	-deox-
yguanosine, and reduced glutathione)
and NO in urine and renal cortex were no
different from that observed in normal
control rats, but when reinstitution of
good control was delayed for 6 months
after induction of diabetes, oxidative
stress and NO remained elevated in both
urine and renal cortex (24). These data
suggest that hyperglycemia-induced oxi-
dative stress and NO, as well as activation
of apoptosis and the NF-B, can be pre-
vented if good glycemic control is initi-
ated early, but are not easily reversed if
poor control is maintained for longer du-
rations. Therefore, these ﬁndings suggest
a persistence of the hyperglycemia-
induced damage in such organs, even af-
ter its normalization.
However,ifexcessreactivespeciesare
centralindevelopmentofhyperglycemia-
related diabetic complications, could this
excess explain the persistence of the risk
for complications, even when the hyper-
glycemia is reduced or normalized?
The above reported studies suggest
that long-lasting effects of hyperglycemia
result in increased oxidative stress, while
inhibitingoxidativestresshaspreliminar-
ily been shown to reverse these effects
(21). Mitochondrial overproduction of
superoxide in hyperglycemia has been
suggestedasthe“unifyinghypothesis”for
the development of diabetic complica-
tions (2). Therefore, it is reasonable that
mitochondria are also important players
in propagating the “metabolic memory.”
Chronichyperglycemiaisthoughttoalter
mitochondrialfunctionthroughglycation
of mitochondrial proteins (25). Levels of
methylglyoxal, a highly-reactive -dicar-
bonil byproduct of glycolysis, are in-
creased in diabetes (26). Methylglyoxal
readily reacts with arginine, lysine, and
sulfhydryl groups of proteins (26) in ad-
dition to nucleic acids (26), inducing the
formationofavarietyofstructurallyiden-
tiﬁed AGEs, in both target cells and
plasma (26). Methylglyoxal has an inhib-
itory effect on mitochondrial respiration,
and methylglyoxal-induced modiﬁca-
tions are targeted to speciﬁc mitochon-
drial proteins (26). These premises are
important because a recent study has
described, for the ﬁrst time, a direct rela-
tionship between the formation of
intracellular AGEs on mitochondrial pro-
teins, the decline in mitochondrial func-
tion, and the excess formation of reactive
species(25).Therefore,mitochondrialre-
spiratory chain proteins that underwent
glycationwerepronetoproducemoresu-
peroxide, independently from the level of
hyperglycemia. The glycation of mito-
chondrial proteins may be a contributing
explanation for the phenomenon of the
“metabolicmemory.”Glycatedmitochon-
dria overproducing free radicals, inde-
pendently from actual glycemia, can lead
to a catastrophic cycle of mitochondrial
DNA damage, as well as functional de-
cline, further oxygen radical generation,
and cellular injury, maintaining the acti-
vation of the pathways involved in the
pathogenesis of diabetic complications
(27). Furthermore, mitochondrial pro-
teins become damaged or post-translation-
ally modiﬁed as a consequence of a major
change in a cell’s redox status (27). This,
on the other hand, may also affect mito-
chondrially destined proteins that are im-
ported into the mitochondrial outer
membrane, inner membrane, or matrix
spaceviaspeciﬁcimportmachinerytrans-
port components (27).
In other words, it may be postulated
that in the “metabolic memory,” the cas-
cade of events is the same as that pro-
posed by Brownlee (2). The source of
superoxide is still the mitochondria, but
that, in addition, the production of reac-
tivespeciesisunrelatedtothepresenceof
hyperglycemia, depending on the level of
glycation of mitochondrial proteins.
HOW COULD OXIDATIVE
STRESS BE REDUCED WITH
PHARMACOLOGICAL AND
NONPHARMACOLOGICAL
INTERVENTIONS?
Antioxidanttherapymaybeofgreatinter-
estindiabeticpatients.However,theclas-
sical antioxidants, such as vitamins E and
C, do not appear to be helpful. New in-
sight into the mechanisms leading to the
generation of oxidative stress in diabetes
are now available. Presumably these ﬁnd-
ings lead to the discovery and evaluation
of new antioxidant molecules, such as su-
per oxide dysmuthase and catalase mi-
metics, which may, at an early stage,
hopefully inhibit the mechanism leading
todiabeticcomplications(3).Whilewait-
ing for these new and speciﬁc com-
pounds, it is reasonable to suggest that
substances already available, such as st-
atins, ACE inhibitors, and angiotensin I
blockers, should also be used for their
effectiveness as “causal and preventive”
antioxidants(rev.in3).However,newin-
triguingperspectivesarearising.Whereas
clinical trials with antioxidant vitamins
have been unsuccessful in preventing
CVDindiabeticandnondiabeticpatients,
itiswellrecognizedthattheconsumption
offreshfruitandvegetablesisparticularly
helpful. Foods of plant origin, despite
plenty of nutrients, contain many non-
nutritional compounds, which may pre-
vent oxidative stress–induced damage.
There are at least two hypothetical new
beneﬁcial mechanisms that can be related
to vegetable consumption: one is the pos-
sibility that compounds such as -lipoic
acid and carnitine may regulate free radi-
cal over-generation at the mitochondrial
level (3), and a second is the possibility of
increasing their own intracellular de-
fenses (28). Plants produce thousands of
phenolic compounds as secondary me-
tabolites, such as nitrous compounds.
Glucosinolates are responsible for the se-
cretion of detoxifying enzymes that re-
move free radicals from the organism
(28). Furthermore, they activate proteins
and phase 2 detoxifying enzymes (28). In
particular, the consumption of crucifer-
ous vegetables has long been associated
with a reduced risk in the occurrence of
canceratvarioussites,includingthepros-
tate, lung, breast, and colon (29). This
protective effect is attributed to isothio-
cyanates present in these vegetables. Sul-
foraphane, found in broccoli, is by far the
most extensively studied to uncover the
mechanisms behind this chemoprotec-
tion (29). The major mechanism by
which sulforaphane protects cells was
traditionally thought to be through
Nrf2-mediated induction of phase 2 de-
toxiﬁcation enzymes that elevate cell de-
fense against oxidative damage and
promote the removal of carcinogens (29).
However, it is becoming clear that there
are multiple mechanisms activated in re-
sponse to sulforaphane, including sup-
pression of cytochrome P450 enzymes,
induction of apoptotic pathways, sup-
pression of cell cycle progression, in-
hibition of angiogenesis, and anti-
inﬂammatoryactivity.Thisnewapproach
appears very promising, and it seems rea-
Ceriello and Testa
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diabetes (Fig. 2).
CONCLUSIONS — Oxidative stress
is convincingly a key pathogenetic factor
for diabetic complications. However, de-
spite this strong evidence, the usefulness
of antioxidants in preventing such com-
plications is still elusive.
New “antioxidants” are emerging,
basedonnewﬁndingsonoxidativestress,
inparticularonhowtheoxidativestressis
produced by the balance between free
radical production and antioxidant de-
fenses. The “new antioxidant” approach
includes the possibility of controlling free
radical production and of increasing in-
tracellular antioxidant defenses, a con-
cept different from the old one, when
antioxidant action meant just scavenging
the free radicals already produced. The
newview,ofcourse,needstobeprovenin
clinicaltrials,butitseemsverypromising.
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